yourstate.us
21 CFR 522.2615

§ 522.2615 Tripelennamine.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 522.2615, § 522.2615 Tripelennamine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87559
Permanent ID
ys:prov:87559@1
SHA-256
bc773800fb4d8a16e2677f78f8f55dfc2914b9147cdb2b2bc776402bc88205a9

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) of tripelennamine hydrochloride. (b) Sponsors. See Nos. 016592 and 051031 in § 510.600(c) of this chapter. (c) Related tolerances. See § 556.741 of this chapter. (d) Conditions of use—(1) Dogs and cats—(i) Amount. Administer 0.5 mg per pound of body weight by intramuscular injection. (ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease. (iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (2) Horses—(i) Amount. Administer 0.5 mg per pound of body weight by intramuscular injection. (ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease. (iii) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (3) Cattle—(i) Amount. Administer 0.5 mg per pound of body weight by intravenous or intramuscular injection. (ii) Indications for use. For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease. (iii) Limitations. Milk taken during treatment and for 24 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 4 days following the last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.